- |||||||||| Shanchol (oral cholera vaccine) / Sanofi
Trial completion, Trial completion date, Trial primary completion date: SCVB: Single Dose Oral Cholera Vaccine Study in Dhaka, Bangladesh (clinicaltrials.gov) - Mar 20, 2018 P3, N=204438, Completed, Active, not recruiting --> Completed Recruiting --> Completed | Trial completion date: Jan 2016 --> Dec 2017 | Trial primary completion date: Jan 2016 --> Dec 2017
- |||||||||| Trial initiation date, Trial primary completion date: Safety and Immunogenicity Study of GX-70 in TB Patient (clinicaltrials.gov) - Mar 15, 2018
P1, N=18, Not yet recruiting, Recruiting --> Completed | Trial completion date: Jan 2016 --> Dec 2017 | Trial primary completion date: Jan 2016 --> Dec 2017 Initiation date: May 2017 --> Mar 2018 | Trial primary completion date: Mar 2018 --> Aug 2018
- |||||||||| Nuvocid (oritavancin) / Melinta Therap
Trial completion, Trial completion date, Trial primary completion date, Adverse events, Real-world evidence, Real-world, Gram positive: A Retrospective Observational Study to Evaluate the Utilization, Outcomes, and Adverse Events in Participants Treated With Orbactiv® (Oritavancin) for Infections Caused by Gram Positive Bacteria in a Real World Setting (clinicaltrials.gov) - Mar 12, 2018 P=N/A, N=325, Completed, Initiation date: May 2017 --> Mar 2018 | Trial primary completion date: Mar 2018 --> Aug 2018 Active, not recruiting --> Completed | Trial completion date: Nov 2017 --> Mar 2018 | Trial primary completion date: Nov 2017 --> Feb 2018
- |||||||||| Minocin for injection (minocycline intravenous) / Melinta Therap
Trial completion date, Trial primary completion date, Adverse events, Real-world evidence, Real-world, Gram negative: A Retrospective Observational Study to Evaluate the Utilization, Outcomes, and Adverse Events in Participants Treated With Minocin (clinicaltrials.gov) - Mar 5, 2018 P=N/A, N=100, Recruiting, Recruiting --> Completed Trial completion date: Dec 2017 --> Apr 2018 | Trial primary completion date: Dec 2017 --> Apr 2018
- |||||||||| mupirocin / Generic mfg.
Trial completion, Trial completion date: HOME2DS: Individualized vs. Household MRSA Decolonization (clinicaltrials.gov) - Feb 28, 2018 P=N/A, N=671, Completed, Trial primary completion date: Jan 2018 --> Jun 2018 | Trial completion date: Mar 2018 --> Aug 2018 Enrolling by invitation --> Completed | Trial completion date: Dec 2017 --> Nov 2017
- |||||||||| Trial completion date, Trial primary completion date, Biopsy: COFFEE: Yield of Cryoprobe vs Flexible Forceps Pleural Biopsy (clinicaltrials.gov) - Feb 20, 2018
P=N/A, N=50, Recruiting, Active, not recruiting --> Completed | Phase classification: P2 --> PN/A Trial primary completion date: Nov 2017 --> Mar 2018 | Trial completion date: Nov 2017 --> Mar 2018
- |||||||||| Enrollment change, Trial withdrawal, HEOR: Impact of Rapid Detection of MRSA (clinicaltrials.gov) - Feb 13, 2018
P=N/A, N=0, Withdrawn, Recruiting --> Completed N=240 --> 0 | Recruiting --> Withdrawn
- |||||||||| ciprofloxacin oral / Generic mfg.
Trial completion, Trial completion date: Ciprofloxacin for the Prevention of Meningococcal Meningitis (clinicaltrials.gov) - Feb 8, 2018 P4, N=300, Completed, Initiation date: Apr 2013 --> Jul 2013 | Completed --> Terminated; The study was stopped early due to feasibility concerns. Active, not recruiting --> Completed | Trial completion date: Dec 2017 --> Jun 2017
- |||||||||| rifampicin / Generic mfg.
Trial completion, Trial completion date: Accuracy and Feasibility of Xpert Ultra (clinicaltrials.gov) - Feb 8, 2018 P=N/A, N=1400, Completed, Active, not recruiting --> Completed | Trial completion date: Dec 2017 --> Jun 2017 Recruiting --> Completed | Trial completion date: Mar 2017 --> Oct 2017
- |||||||||| Trial completion date, Trial initiation date, Trial primary completion date, HEOR, Real-world evidence, Real-world: Effect of Xpert MTB/RIF on Patient Outcomes (clinicaltrials.gov) - Feb 5, 2018
P=N/A, N=892, Active, not recruiting, Trial primary completion date: Dec 2017 --> Dec 2018 | Trial completion date: Dec 2017 --> Dec 2018 Initiation date: Jan 2016 --> Jun 2016 | Trial primary completion date: Aug 2017 --> Feb 2018 | Trial completion date: Dec 2017 --> Dec 2018
- |||||||||| apremilast / Generic mfg.
Trial completion, Trial completion date, Trial primary completion date: SMASH: Short-term Safety, Efficacy and Mode of Action of Apremilast in Moderate Suppurative Hidradenitis (clinicaltrials.gov) - Feb 5, 2018 P2, N=20, Completed, Initiation date: Jan 2016 --> Jun 2016 | Trial primary completion date: Aug 2017 --> Feb 2018 | Trial completion date: Dec 2017 --> Dec 2018 Active, not recruiting --> Completed | Trial completion date: Dec 2017 --> Dec 2017 | Trial primary completion date: Nov 2017 --> Dec 2017
- |||||||||| Cubicin (daptomycin) / Merck (MSD)
Trial completion, Enrollment change: IL-10 Stratifying Tool for Towards Antibiotic Selection for MRSaB (clinicaltrials.gov) - Feb 1, 2018 P4, N=40, Completed, Active, not recruiting --> Completed | Trial completion date: Dec 2017 --> Dec 2017 | Trial primary completion date: Nov 2017 --> Dec 2017 Recruiting --> Completed | N=50 --> 40
- |||||||||| Enrollment change, Trial primary completion date: Helicobacter Pylori Sample Collection Protocol Post Therapy Subjects (clinicaltrials.gov) - Feb 1, 2018
P=N/A, N=20, Recruiting, Not yet recruiting --> Completed | N=1250 --> 810 | Trial primary completion date: Feb 2017 --> Nov 2017 N=100 --> 20 | Trial primary completion date: Dec 2017 --> Mar 2018
- |||||||||| Trial completion, IO biomarker: Multi-Drug Resistant Tuberculosis in Korea (clinicaltrials.gov) - Jan 31, 2018
P=N/A, N=2040, Completed, Active, not recruiting --> Completed Active, not recruiting --> Completed
- |||||||||| levofloxacin / Generic mfg.
Trial completion, Trial primary completion date: PK of Levofloxacin in MDR-TB Patients (clinicaltrials.gov) - Jan 25, 2018 P=N/A, N=20, Completed, Not yet recruiting --> Recruiting | Trial primary completion date: Dec 2017 --> Dec 2018 Recruiting --> Completed | Trial primary completion date: May 2017 --> Oct 2017
- |||||||||| niclosamide topical (ATx 201) / UNION Therap
Trial primary completion date: Evaluation of ATx201 as a Topical Antibiotic Agent (clinicaltrials.gov) - Jan 17, 2018 P1/2, N=76, Recruiting, N=300 --> 218 | Recruiting --> Terminated; Sponsor lack of funding Trial primary completion date: Nov 2017 --> Feb 2018
- |||||||||| RotaTeq (Live attenuated pentavalent Rotavirus oral vaccine) / Merck (MSD), Vaxelis (diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed, inactivated poliovirus, haemophilus b conjugate and hepatitis B vaccine) / Merck (MSD), Sanofi
Trial primary completion date: A Study of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-006) (clinicaltrials.gov) - Dec 26, 2017 P3, N=2808, Completed, Active, not recruiting --> Completed Trial primary completion date: Jul 2013 --> Dec 2012
- |||||||||| Trial completion: TDAP Safety in Pregnant Women (clinicaltrials.gov) - Dec 20, 2017
P=N/A, N=375, Completed, Active, not recruiting --> Completed Active, not recruiting --> Completed
|